Showing 6,081 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP science

Long-acting injectable multi-drug implant shows promise for HIV prevention and treatment

Editor's pick
EurekAlert
23 September 2019
Changing treatment

FDA Expands Indications for Pifeltro and Delstrigo for HIV

Editor's pick
Medscape (requires free registration)
23 September 2019
Treatment outcomes & life expectancy

What’s causing deaths among HIV-positive people in San Francisco?

Editor's pick
CATIE
23 September 2019
Drug interactions & pharmacokinetics

Interaction between antiretroviral boosters and corticosteroids can lead to development of Cushing's syndrome

News
20 September 2019
Starting treatment

Same-day initiation of ART feasible and safe without CD4 counts, Thai study shows

News
18 September 2019
Cardiovascular disease

Switching Back to Older Tenofovir Improves Lipid Levels

Editor's pick
POZ
12 September 2019
Adherence

Adherence to ART: is the gold standard still needed for viral suppression?

News
2 September 2019
Contraception

AVAC’s Take on Updated WHO Guidance on Hormonal Contraception and HIV Risk

Editor's pick
AVAC
29 August 2019
Contraception

Guidance statement - Recommendations on contraceptive methods used by women at high risk of HIV

Editor's pick
World Health Organization
29 August 2019
Treatment outcomes & life expectancy

HIV-positive New Yorkers are living longer but still dying from underlying infection, not just from old age

Editor's pick
EurekAlert
29 August 2019
Side effects

Those Truvada Lawsuit Ads You See Everywhere May Hinder Public Health Efforts

Editor's pick
TheBody
28 August 2019
Cardiovascular disease

Combining statins and physical exercise has big benefits for people with HIV and high lipids

News
28 August 2019
Changing treatment

‘Alarming’ rates of second-line HIV treatment failure in sub-Saharan Africa

Editor's pick
Avert
22 August 2019
HIV treatment for children & young people

Dolutegravir for younger children: results from the ODYSSEY trial

Editor's pick
HIV i-Base
22 August 2019
New & experimental HIV treatments

ViiV Healthcare reports positive phase III study results of investigational, long-acting, injectable HIV-treatment regimen administered every two months

Editor's pick
GSK press release
22 August 2019
Mental & emotional health problems

Massive decline in suicides of HIV-positive people since the introduction of combination therapy, but rate remains high

News
21 August 2019
Bad science & bogus treatments

Catfished by a Fake AIDS Conference!

Editor's pick
TheBody
20 August 2019
Adherence

Directly observed therapy can be a useful tool in caring for people with HIV treatment failure

News
13 August 2019
Kidney problems

Change in Kidney Function After TDF-to-TAF Switch: Who Benefits Most?

Editor's pick
NATAP
10 August 2019
Injectable & long-acting HIV treatment

DURECT and Gilead Enter into License Agreement for Long-Acting Injectable HIV Investigational Product

Editor's pick
DURECT press release
6 August 2019
People with limited treatment options

Dramatic decline in proportion of people with extensive resistance to anti-HIV medications

News
6 August 2019
Resistance

Alarming surge in drug-resistant HIV uncovered

Editor's pick
Nature
3 August 2019
Changing treatment

High efficacy from switching to bictegravir/F/TAF in virally suppressed participants – including analyses by baseline drug resistance

Editor's pick
i-Base
2 August 2019
People with limited treatment options

Clinical and Economic Effects of Ibalizumab for Multidrug-Resistant HIV

Editor's pick
Infectious Disease Advisor
2 August 2019